Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI study.

Autor: Azuma T; Azuma Rheumatology Clinic, Saitama, Japan., Misaki K; Department of Rheumatology, Kita-Harima Medical Center, Hyogo, Japan., Kusaoi M; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan., Suzuki Y; Izumi Himawari Clinic, Miyagi, Japan., Higa S; Division of Rheumatology, Daini Osaka Police Hospital, Osaka, Japan., Kumon Y; Department of Rheumatology, Chikamori Hospital, Kochi, Japan., Yoshitama T; Yoshitama Clinic for Rheumatic Diseases, Kagoshima, Japan., Naniwa T; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University, Aichi, Japan., Yamada S; Department of Clinical Immunology, Osaka City University, Osaka, Japan., Okano T; Department of Orthopedic Surgery, Osaka City University, Osaka, Japan., Takeuchi K; Departments of Orthopedics and Rheumatology, Isesaki Fukushima Hospital, Gunma, Japan., Ikeda K; Department of Allergy and Clinical Immunology, Chiba University, Chiba, Japan., Higami K; Higami Clinic of Rheumatology and Diabetology, Nara, Japan., Inoo M; Utazu Hospital, Kagawa, Japan., Sawada T; Department of Rheumatology, Tokyo Medical University, Tokyo, Japan., Kang C; Kang Clinic Rheumatology Orthopedic, Kanagawa, Japan., Hayashi M; Hayashi Rheumatology Orthopaedic Clinic, Nagano, Japan., Nagaya Y; Center of Joint Surgery for Rheumatic Diseases and Osteoporosis, Nagoya City University East Medical Center, Aichi, Japan., Hagiwara T; Department of Rheumatology, Takarazuka City Hospital, Hyogo, Japan., Shono E; Shono Rheumatology Clinic, Fukuoka, Japan., Himeno S; Himeno Hospital, Fukuoka, Japan., Tanaka E; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan., Inoue E; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Showa University Research Administration Center, Showa University, Tokyo, Japan., Yoshizawa Y; Department of Immunology Medical, Bristol-Myers Squibb K.K., Tokyo, Japan., Kadode M; Medical Affairs, Ono Pharmaceutical Co., Ltd., Osaka, Japan., Yamanaka H; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Department of Rheumatology, Sanno Medical Center, Tokyo, Japan., Harigai M; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.

Publikováno v: Modern rheumatology [Mod Rheumatol] 2023 Mar 02; Vol. 33 (2), pp. 271-278.

Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy.

Autor: Sugihara K; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Wakiya R; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Shimada H; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Kameda T; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Nakashima S; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Kato M; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Miyagi T; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Mizusaki M; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Mino R; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Nomura Y; Department of Orthopaedic Surgery, Faculty of Medicine, Kagawa University, Japan., Inoo M; Department of Rheumatology, Utazu Hospital, Japan., Kadowaki N; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan., Dobashi H; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Japan.

Publikováno v: Internal medicine (Tokyo, Japan) [Intern Med] 2022 Jul 01; Vol. 61 (13), pp. 1953-1958. Date of Electronic Publication: 2022 Apr 23.

Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial.

Autor: Tanaka Y; Department of the First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan tanaka@med.uoeh-u.ac.jp., Oba K; Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Hokkaido, Japan., Koike T; Department of Clinical Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan., Miyasaka N; Department of Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan., Mimori T; Department of Rheumatology, Ijinkai Takeda General Hospital, Kyoto, Japan., Takeuchi T; Department of Rheumatology, Keio University, School of Medicine, Tokyo, Japan., Hirata S; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan., Tanaka E; Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan., Yasuoka H; Department of Rheumatology, Keio University, School of Medicine, Tokyo, Japan., Kaneko Y; Department of Rheumatology, Keio University, School of Medicine, Tokyo, Japan., Murakami K; Deapartment of Rheumatology and Clinical Immunology, Kyoto University, Kyoto, Japan., Koga T; Department of Immunology and Rheumatology, Nagasaki University, Nagasaki, Japan., Nakano K; Department of the First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Amano K; Department of Rheumatology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan., Ushio K; Ushio Clinic, Osaka, Japan., Atsumi T; Department of Clinical Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan., Inoo M; Utazu Hama Clinic, Ayauta-gun, Kagawa, Japan., Hatta K; Department of General Medicine, Tenri Hospital, Tenri, Japan., Mizuki S; The Centre for Rheumatic Diseases, Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan., Nagaoka S; Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan., Tsunoda S; Division of Rheumatology, Hyogo College of Medicine, Nishinomiya, Japan., Dobashi H; Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Miki, Japan., Horie N; Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Hokkaido, Japan., Sato N; Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Jan; Vol. 79 (1), pp. 94-102. Date of Electronic Publication: 2019 Oct 19.

Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study

Autor: Ogata, Atsushi, Amano, Koichi, Dobashi, Hiroaki, Inoo, Masayuki, Ishii, Tomonori, Kasama, Tsuyoshi, Kawai, Shinichi, Kawakami, Atsushi, Koike, Tatsuya, Miyahara, Hisaaki, Miyamoto, Toshiaki, Munakata, Yasuhiko, Murasawa, Akira, Nishimoto, Norihiro, Ogawa, Noriyoshi, Ojima, Tomohiro, Sano, Hajime, Shi, Kenrin, Shono, Eisuke, Suematsu, Eiichi, Takahashi, Hiroki, Tanaka, Yoshiya, Tsukamoto, Hiroshi, Nomura, Akira, Amano, K., Atsumi, T., Dobashi, H., Fukuda, T., Hashimoto, J., Hirabayashi, Y., Inaba, M., Inoo, M., Inoue, H., Ishigatsubo, Y., Ishiguro, N., Ishii, T., Iwahashi, M., Kai, M., Kasama, T., Kawabata, D., Kawai, S., Kawakami, A., Kida, D., Kohsaka, H., Koike, T., Kondo, M., Matsubara, T., Matsumura, R., Minota, S., Miyahara, H., Miyamoto, T., Mukai, M., Munakata, Y., Murasawa, A., Nishimoto, N., Ogawa, N., Ohta, S., Ojima, T., Saeki, Y., Sano, H., Shi, K., Shono, E., Suematsu, E., Sugimoto, K., Sugimoto, T., Sumida, T., Takahashi, H., Takasugi, K., Takeuchi, T., Tamaki, S., Tanaka, T., Tanaka, Y., Tanimura, K., Tohma, S., Tsukamoto, H., Ueki, Y., Urata, Y., Yamamoto, K., Yamanaka, H., Yoshifuji, H.

Publikováno v: Journal of Rheumatology; 2015, Vol. 42 Issue: 5 p799-809, 11p

Changes in foot function, disease activity, and disability after forefoot resection arthroplasty in patients with rheumatoid arthritis.

Autor: Sawachika F; Department of Preventive Medicine, Institute of Biomedical Sciences, the University of Tokushima Graduate School., Uemura H, Katsuura-Kamano S, Yamaguchi M, Bahari T, Miki K, Todo S, Inoo M, Onishi I, Kurata N, Arisawa K

Publikováno v: The journal of medical investigation : JMI [J Med Invest] 2016; Vol. 63 (1-2), pp. 38-44.